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Summary 
Health-care expenditure for cardiovascular disease (CVD) is higher than for any other 
disease group and the impact of CVD on the health of Australians is considerable. This 
report draws upon data from the AIHW Disease Expenditure Database to provide a 
summary of health-care expenditure for CVD in Australia in 2008–09 as well as an overview 
of how this expenditure has changed in the last decade. 
The report is based primarily on CVD expenditure for the following health-care sectors: 
hospital admitted patient services, out-of-hospital medical expenses and prescription 
pharmaceuticals.  
Main findings  
• CVD has the highest level of health-care expenditure of any disease group in Australia, 
ranking it ahead of oral health, mental disorders and musculoskeletal conditions. In 
2008–09, estimated expenditure for CVD, allocated by health-care sector, was $7,605 
million—12% of all allocated health-care expenditure in Australia.  
• CVD expenditure has remained relatively stable at around 12% of all health-care 
expenditure for the period 2000–01 to 2008–09. 
• Coronary heart disease expenditure accounted for over one-quarter of CVD expenditure 
in 2008–09 (27%). 
• Hospital admitted patient services accounted for most CVD expenditure (conservatively 
estimated at $4,460 million), followed by prescription pharmaceuticals ($1,648 million) 
and out-of-hospital medical expenses ($1,497 million), in 2008–09. 
• After adjusting for inflation, the biggest increase in annual CVD health-care expenditure 
from 2000–01 to 2008–09 was for hospital admitted patient services, which increased by 
55%. 
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1 Introduction 
The burden of cardiovascular disease (CVD; see Box 1.1) is high in Australia and continues, 
despite some major gains, to have a large impact on the health of Australians in terms of 
prevalence, mortality, morbidity and expenditure. It affected 3.4 million Australians in 
2007–08 (17% of the population), is Australia’s biggest killer, responsible for 48,456 deaths 
(34% of all deaths in 2008) and was the main reason for 474,200 hospitalisations (6% of all 
hospitalisations in 2008-09). CVD was also an additional, or secondary, diagnosis in a further 
630,000 hospitalisations in Australia (ABS 2009; AIHW 2011).  
Box 1.1: Definition of CVD and its causes 
CVD is a term used to describe many different conditions that affect the heart and blood 
vessels, with coronary heart disease (heart attack and angina) and stroke being the most 
common and serious types of CVD. The main underlying cause of CVD is a process known 
as atherosclerosis where abnormal deposits of fat, cholesterol and other substances build up 
in the inner lining of the arteries to form plaque. Atherosclerosis is most serious when it 
leads to reduced or blocked blood supply to the heart (causing angina or heart attack) or to 
the brain (causing stroke). A number of factors are known to increase the risk of developing 
CVD. These include tobacco smoking, high blood pressure, high blood cholesterol, 
insufficient physical activity, overweight and obesity, poor nutrition and diabetes (AIHW 
2010) (see Appendix B for further details on CVD conditions and its risk factors).  
In Australia, mortality rates for CVD have been falling since the 1960s (AIHW 2011). This can 
in part be attributed to improved diagnosis and treatment, including a marked increase in 
the use of statins, anti-hypertensive and anti-thrombolytic medications (Briffa et al. 2009), as 
well as reduced rates of smoking and improvements in the rates of high blood pressure 
(Taylor et al. 2006). Because CVD is strongly associated with age, the decline in mortality 
rates has resulted in an increasingly greater proportion of those with CVD belonging to older 
age groups where per person expenditure is highest. This combination of an ageing 
population, improved CVD survival and increased per person expenditure has put upward 
pressure on overall CVD expenditure. 
This report aims to provide an overview of CVD expenditure by presenting health-care 
expenditure estimates for the treatment of CVD in 2008–09 and comparative information for 
the period 2000–01 to 2008–09. The term ‘expenditure’ used in this report refers to 
expenditure that can be allocated by disease and, as explained in the Methods and 
limitations chapter, this covers approximately 70% of total health-care expenditure in 
Australia. 
CVD expenditure is presented by sex, age and type of CVD and is based primarily on 
expenditure for the health-care sectors: hospital admitted patient services, out-of-hospital 
medical expenses and prescription pharmaceuticals. 
Coronary heart disease (CHD) and stroke are the most prevalent types of CVD and it is only 
for these diseases that expenditure can be specifically allocated. While other types of CVD, 
such as heart failure, rheumatic fever and rheumatic heart disease, peripheral vascular 
disease, hypertension, hypertensive heart disease consume 65% of total expenditure on CVD, 
data limitations mean it is not possible to analyse expenditure for these diseases individually 
and in this report they are treated collectively as ‘Other CVD’.  
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2 Methods and limitations 
Generally, the method for estimating disease expenditure is a ‘top–down’ approach where 
total expenditure across the health system is estimated and then allocated to the relevant 
conditions. Although this method yields consistency, good coverage and totals that add up 
to known expenditure, it is not as sensitive or accurate for any specific disease as a detailed 
‘bottom–up’ analysis which would include the actual costs incurred by patients with that 
disease. In most cases however, a lack of data means a more granular ‘bottom-up’ analysis is 
not possible. 
The AIHW Disease Expenditure Database 
The predominant source of information for this report is the AIHW Disease Expenditure 
Database. It provides a broad picture of the use of health system resources classified by 
disease group, and is a reference source for planners and researchers interested in costs and 
use patterns for particular disease groups. This information is also useful for comparing 
expenditure for different diseases and for ranking diseases by levels of expenditure.  
Estimates in the Disease Expenditure Database are derived by combining information from 
the National Hospital Morbidity Database (NHMD), the National Public Hospitals 
Establishments Database (NPHED), the Health Expenditure Database, the National Hospital 
Cost Data Collection (NHCDC) and the Bettering the Evaluation and Care of Health 
(BEACH) survey.  
The AIHW is continually seeking to improve the methods used to produce these estimates. 
As a consequence, disease expenditure estimates are subject to revision and the most recently 
published results may not be directly comparable with previously published data. 
The Disease Expenditure Database contains estimates of expenditure by disease category, 
age group and sex for admitted patient hospital services, out-of-hospital medical expenses, 
prescription pharmaceuticals, optometrical and dental services, community mental health 
services and public health cancer screening.  
A data quality statement for the Disease Expenditure Database can be found in Appendix C. 
It provides information on aspects of the quality of the data being reported by the AIHW and 
is included to help readers understand the limitations of the data and make informed 
judgments about their use of the data. 
Health-care expenditure exclusions and limitations 
It is not possible to allocate all expenditure on health goods and services by disease. 
Expenditure that could not be allocated by disease includes: capital expenditure, non-
admitted patient hospital services, over-the-counter drugs, other health practitioner services 
(except optometry), community health services expenditure (except community mental 
health), expenditure on public health programs (except cancer screening programs), health 
administration, health aids and appliances, and patient transport (ambulance). As a result, 
the estimates in this report are conservative as they are based on approximately 70% of total 
direct health expenditure that can be allocated by disease (AIHW 2010). Expenditure for 
residential aged care is not included in this report because it is categorised as welfare 
expenditure rather than health-care expenditure. 
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Treatments of dyslipidaemias, such as high blood cholesterol, are classified to the 
‘Endocrine, nutritional and metabolic disorders’ chapter in the International Statistical 
Classification of Diseases and Related Health Problems, 10th Revision, Australian 
Modification (ICD-10-AM). As these treatments are also used for the management of CVD 
this leads to an underestimation of the total expenditure on medicines used to prevent and 
treat CVD. Similarly, pathology tests for dyslipidaemias would be included in CVD 
expenditure only if the reason given for ordering the tests was a cardiovascular problem.  
Readers need to bear in mind that cost-of–illness data provide estimates only of the impact a 
disease has on health-care expenditure. The estimates of the cost of treating and/or 
preventing a disease cannot be used to indicate the loss of health due to that disease, or to 
understand other effects, such as loss of productivity.  
Care should be taken not to interpret expenditure associated with disease treatment as 
simply an estimate of the savings that would result from prevention of disease. Conversion 
of the opportunity cost—or the benefits forgone—of resources being devoted to disease 
treatment into expenditure savings involves a number of additional considerations. See, for 
example, Disease costing methodology used in the Disease Costs and Impact Study 1993–94 
(AIHW: Mathers & Penm 1998). 
Hospital admitted patient services 
Expenditure for hospital admitted patient services is based on hospital separations (episodes 
of care) using the principal diagnosis for each separation, with diagnosis information coded 
to the ICD-10-AM. No expenditure is allocated for additional diagnoses. In 2008–09, CVD 
was a principal diagnosis in 474,171 hospitalisations and an additional diagnosis in a further 
629,882 hospitalisations, which suggests that expenditure for hospital admitted patient 
services is likely to be a conservative estimate of the true level of CVD-related expenditure.  
In this report, expenditure was assigned to CVD when the principal diagnosis was between 
ICD-10-AM codes I0 and I99, inclusively. Within this range, expenditure was ascribed to 
CHD using the ICD–10-AM codes I20 to I25, to stroke using codes I60 to I64 and to Other 
CVD using the remaining codes. For further information about ICD-10-AM coding, refer to 
ICD version D (WHO 2010). 
Grouping a large number of diseases for analytical purposes, as has been done with ‘Other 
CVD’, has the potential to mask expenditure patterns for individual diseases within this 
group. 
Unless specifically assigned to CVD as a principal diagnosis, expenditure on complications 
of CVD, such as diabetes, or kidney disease, is allocated to those diseases and not included in 
CVD expenditure. If, for example, the principal diagnosis for a hospital separation was 
diabetes, with an additional diagnosis of CVD, then all the expenditure associated with that 
separation would be counted as expenditure for diabetes. The expenditure associated with 
treating CVD while that patient was in hospital would not be captured. By way of 
illustration, in 2008–09, 47% of hospitalisations with a principal diagnosis of diabetes had an 
additional diagnosis of CVD. 
Out-of-hospital medical expenses and prescription pharmaceuticals 
Expenditure estimates for out-of-hospital medical expenses and prescription 
pharmaceuticals presented in this report are derived using the BEACH survey in conjunction 
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with data from other sources including the Medicare Benefits Schedule (MBS), 
Pharmaceutical Benefits Scheme (PBS), Repatriation Pharmaceutical Benefits Scheme (RPBS), 
and script volumes for private and under co-payment drugs. The BEACH data were 
collected by the Family Medicine Research Centre of the University of Sydney under a 
previous collaboration with the AIHW. 
For out-of-hospital medical expenses, the BEACH survey data were aggregated over 3 years 
to ensure the sample size was sufficiently large to perform the analysis required. The 
aggregated data were used to estimate the proportion of general practitioner (GP) encounters 
in which CVD was a ‘problem managed’. This proportion was then applied to the MBS data 
for the reference year. Based on this method, expenditure can be allocated for GP visits and 
referrals to medical specialists, pathology and imaging, referred to throughout this report as 
out-of-hospital medical expenses. 
For prescription pharmaceuticals, the BEACH survey data were aggregated over 3 years to 
allocate expenditure on prescription drugs to each disease group based on the problems 
managed in the GP encounter that related to the prescribing of a particular drug. The 
Anatomical Therapeutic Chemical Classification System codes were mapped to codes for 
prescription drugs used in the BEACH survey.  
The method for distributing prescription medicines expenditure by disease relies largely on 
general practice prescription data. For diseases where a significant proportion of 
prescriptions are made by medical specialists, as may be the case with CVD, this may not 
accurately reflect prescription medicine expenditure because it assumes that prescribing 
patterns for GPs and medical specialists are the same. This assumption was applied because 
there are no data that permit allocation of specialist-written prescriptions to diseases. 
Time series comparisons for both out-of-hospital medical expenses and prescription 
pharmaceuticals should be treated with caution because GP prescription and referral 
patterns may have varied over time. Pharmaceuticals dispensed in hospitals were included 
in the estimates of hospital costs. 
Per person and per service expenditure 
All per person calculations of expenditure in this report have been derived using the whole 
Australian population at 30 December 2008 as the denominator (ABS 2012). This method has 
been adopted because there are no reliable prevalence data for diagnosed CVD in Australia 
for 2007–08. Data from the NHS for that period were self-reported and regarded as 
insufficiently reliable. Using the whole population produces a valid economic measure 
which allows per person expenditure to be compared across diseases and with results from 
the earlier AIHW report ‘Health-care expenditure on cardiovascular diseases 2004–05’. Per 
person expenditure results are published in chapter 5 of the report. If reliable prevalence 
data had been available for the period under study, an additional, and perhaps more useful, 
measure of per person expenditure could have been calculated for people who have CVD. 
In chapter 6 of the report, per service expenditure for hospital admitted patients was 
analysed using the number of hospital separations as the denominator (where the principal 
diagnosis was CVD). Per service analysis was not undertaken for out-of-hospital medical 
expenses or prescription pharmaceuticals due to the lack of an appropriate administrative 
data source. 
In this report 2003 Burden of Disease (BoD) coding was used to compare expenditure 
estimates for different disease groups. This was necessary because the ICD-10-AM coding, 
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which has been used for the balance of the report, could not be used in this instance (see 
appendix A for the codes used from both classifications) . The 2003 BoD estimates are being 
revised by the AIHW and new information describing BoD in Australia is expected to be 
finalised in 2015.  
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3 How much is spent on cardiovascular 
diseases? 
Overall expenditure 
In 2008–09, CVD accounted for 12% ($7,605 million) of allocated health-care expenditure in 
Australia—more than any other disease group. This reflects the fact that CVD has long been 
one of the leading causes of disease and injury in Australia (AIHW: Begg et al. 2007). Oral 
health, mental disorders, musculoskeletal conditions, injuries and neoplasms were the next 
five disease groups ranked in order of allocated health-care expenditure, accounting for 
between 7% and 10% of such expenditure (Figure 3.1). 
 
Notes 
1. This figure uses 2003 burden of disease coding so that all major disease groups could be included. It should be noted that data based on 
burden of disease codes may produce slightly different proportions of total expenditure from those derived using ICD-10-AM codes. See 
Appendix A for differences between codes used. 
2. Percentages do not add to 100 because not all disease groups are included. 
Source: Disease Expenditure Database, AIHW. 
Figure 3.1: Health-care expenditure by disease group, Australia, 2008–09 
  
0 2 4 6 8 10 12
Congenital anomalies
Neonatal causes
Skin diseases
Diabetes mellitus
Infectious & parasitic
Maternal conditions
Endocrine, nutritional & metabolic
Nervous system disorders
Genitourinary
Digestive system
Respiratory
Neoplasms
Injuries
Musculoskeletal
Mental disorders
Oral health
Cardiovascular
Per cent of total expenditure 
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Expenditure by health-care sector 
All cardiovascular diseases 
Hospital admitted patient services 
The health-care sector with the highest level of CVD-related expenditure in 2008–09 was 
hospital admitted patient services ($4,460 million), accounting for 59% of total health-care 
expenditure for CVD, the same proportion as for expenditure from all diseases. More than 
474,000 separations with a principal diagnosis of CVD were captured in hospital admitted 
patient services with an average expenditure of $9,406 for each separation (Table 3.1 and 
Table D7). 
Out-of-hospital medical expenses 
Out-of-hospital medical expenses ($1,497 million), accounted for a further 20% of total CVD 
health-care expenditure, slightly less than the proportion for all diseases (24%) (Table 3.1).  
Prescription pharmaceuticals 
Estimated expenditure for prescription pharmaceuticals accounted for nearly one-quarter of 
total health-care expenditure for CVD (22% or $1,648 million), a slightly higher proportion 
than for all diseases (16%) (Table 3.1). 
Table 3.1: Cardiovascular and all disease expenditure by health-care sector, Australia, 2008–09  
 Cardiovascular diseases  All diseases 
Health-care sector $ (million) Per cent  $ (million) Per cent 
Hospital admitted patient services 4,460 58.6  38,675 59.4 
Out-of-hospital medical expenses 1,497 19.7  15,871 24.4 
Prescription pharmaceuticals 1,648 21.7  10,583 16.2 
Total allocated expenditure 7,605 100.0  65,129 100.0 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CVD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
CHD, stroke and Other CVD 
As noted in the Methods and limitations section of the report, separate analyses were 
undertaken for CHD and stroke only. All remaining types of CVD were considered 
collectively as ‘Other CVD’. 
The types of CVD with the highest health-care expenditure were CHD and stroke. CHD 
accounted for over one-quarter of CVD expenditure (27% or 2,028 million) and stroke a 
further 8% ($606 million). The balance of $4,971 million (65%) was spent on Other CVD 
(Table D1). 
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Hospital admitted patient services 
Hospital admitted patient services accounted for the highest level of health-care sector 
spending for CHD, stroke and Other CVD in 2008–09. The contribution of hospital admitted 
patient services to disease expenditure does vary by disease: 92% of total stroke expenditure 
compared with 75% for CHD and 48% for Other CVD (Figure 3.3 and Table D1). However, in 
absolute terms, hospital admitted patient services expenditure for stroke ($560 million) was 
considerably lower than for CHD ($1,517 million) and Other CVD ($2,383 million) (Figure 3.2 
and Table D1). 
Out-of-hospital medical expenses 
In 2008–09, out-of-hospital medical expenses was the sector with the lowest expenditure for 
CHD, stroke and Other CVD. Over one-quarter of expenditure for Other CVD was allocated 
for out-of-hospital medical expenses (26% or $1,276 million). For CHD and stroke the 
proportions were much lower, at 10% ($201 million) and 3% ($21 million) respectively 
(Figure 3.2, 3.3 and Table D1). 
Prescription pharmaceuticals 
In 2008–09, prescription pharmaceuticals accounted for over one-quarter of expenditure for 
Other CVD (26% or $1,311 million) but only 15% ($311 million) of CHD expenditure and 4% 
($26 million) of that for stroke (Figure 3.2, 3.3 and Table D1). 
 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD, stroke or Other CVD was 
the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 3.2 Health-care sector expenditure by type of cardiovascular disease, Australia, 2008–09 
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Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD, stroke or Other CVD was 
the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 3.3 Proportion of health-care sector expenditure by type of cardiovascular disease, Australia, 
2008–09 
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4 Expenditure by age and sex 
Box 4.1: Per person expenditure estimates 
All per person calculations of expenditure in this report have been derived using the whole 
Australian population at 30 December 2008 as the denominator (ABS 2012). This method 
has been adopted because there are no reliable prevalence data for diagnosed CVD in 
Australia for 2007–08. This approach results in much lower per person costs than would 
have been the case if the numbers of people who had the disease (prevalence data) had been 
used. The method used here, however, does provide a valid economic measure of per capita 
expenditure that can be used to compare both individual diseases and results over time. See 
Methods and limitations chapter for more information. 
All cardiovascular diseases 
In 2008–09, total allocated health-care expenditure for all CVD was $4,259 million for males 
and $3,347 million for females. Expenditure was relatively low and there were similar levels 
for males and females up to age 44. In each older age group up to 65-74 for males and 75-84 
for females expenditure was progressively higher. For males 65–74 $1,152 million was spent 
and for females 75–84 $934 million was spent. Expenditure for those aged 85 and over 
declined substantially, although female expenditure ($485 million) was considerably higher 
than for males ($335 million), reflecting the greater longevity of women (Figure 4.1 and Table 
D2). 
 
Source: Disease Expenditure Database, AIHW. 
Figure 4.1: Health-care expenditure for cardiovascular diseases, by age and sex, Australia, 2008–09  
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Overall expenditure on CVD was $352 per person in Australia in 2008–09. More was spent 
on males ($397 per person) than on females ($309). Per person expenditure was relatively 
low and similar for males and females until age 35–44, after which it was higher for men 
than women in all age groups. Per person expenditure was greatest for those 85 and over for 
both men ($2,776) and women ($2,020) (Figure 4.2, Table D6). 
Despite people aged 85 and over having the highest level of per person expenditure ($2,273), 
overall expenditure for this group was relatively low ($820 million compared with $2,015 
million for those 75–84), a result of the smaller population in this age group (Table D2 and 
Table D6). 
 
Source: Disease Expenditure Database, AIHW. 
Figure 4.2: Per person health-care expenditure for cardiovascular diseases, by age and sex, 
Australia, 2008–09 
Most of the difference in expenditure between males and females is related to  
hospital-admitted patient services. In 2008–09, the amount spent on hospital admitted 
patient services for males with CVD was 1.5 times as high as that spent for females ($2,711 
million vs $1,749 million). This reflects the greater number of CVD hospitalisations for males 
(271,600) compared with females (202,600) in 2008–09. For prescription pharmaceuticals and 
out–of–hospital medical expenses however, similar amounts were spent on both sexes 
(Figure 4.3 and Table D2). 
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Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CVD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 4.3: Health-care expenditure for cardiovascular diseases, by sex and health-care sector, 
Australia, 2008–09 ($ million)  
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Coronary heart disease 
In 2008–09, total allocated health-care expenditure for CHD was $1,365 million for males and 
$663 million for females. Expenditure in each older group from age 35–44 was progressively 
higher for both sexes until age 65-74 for men and 75–84 for women. Expenditure was much 
higher for men than women between ages 35 and 84, however, at 85 and over it was slightly 
higher for women. Expenditure reached its highest level for males ($405 million) at 65–74 
and for females ($203 million) at 75–84, showing a similar pattern to that for all CVD. While 
clearly less expenditure was reported for those aged 85 and over, in particular with male 
expenditure much lower than for those aged 75–84, expenditure for women ($90 million) 
was greater than that for men ($77 million) reflecting the larger numbers of women than men 
in this age group (Figure 4.4 and Table D3). 
 
Source: Disease Expenditure Database, AIHW. 
Figure 4.4: Health-care expenditure for coronary heart disease, by age and sex, Australia, 2008–09 
Overall per person expenditure on CHD was $94 in 2008–09. Over twice as much was spent 
on males ($127) as females ($61). Per person expenditure became progressively higher with 
each age group up to age 75–84 for men, and 85 and over for women, and was higher for 
men than women at 35–44 and each subsequent age group. Expenditure per person was 
greatest for males aged 75–84 ($734 and for females aged 85 and over ( $375) (Figure 4.5 and 
Table D6). 
While much of the difference in expenditure between the sexes can be attributed to the 
higher rate of CHD among males (ABS 2009) it may also reflect differences in the diagnosis, 
treatment and care of coronary heart disease between males and females. Expenditure per 
hospital separation may provide a better picture of the difference between the sexes although 
it also shows a greater amount being spent for males ($10,368) than females ($8,685) 
(Table D7). More research in this area is required to better explain the differences in 
expenditure between males and females. 
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Source: Disease Expenditure Database, AIHW. 
Figure 4.5: Per person health-care expenditure for coronary heart disease by age and sex, Australia, 
2008–09 
More was spent on males than females with CHD across each area of expenditure. This was 
especially true for hospital-admitted patients where over twice as much ($1,061 million) was 
spent on males as on females ($456 million). Expenditure on prescription pharmaceuticals for 
males ($198 million) was almost twice as high as it was for females ($113 million) while for 
out-of-hospital medical expenses the levels of expenditure were similar for both sexes 
(Figure 4.6, Table D3). 
 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 4.6: Health-care expenditure for coronary heart disease by sex and health-care sector, 
Australia, 2008–09  
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Stroke 
In 2008–09, total allocated health-care expenditure for stroke was $313 million for males and 
$293 million for females. Expenditure became progressively greater with age for both males 
and females up to age 75–84 where $91 million was spent on men and $93 million was spent 
on women. Expenditure was higher for men than for women between 45 and 74 years of age. 
Expenditure was lower for those aged 85 and over for both sexes, in particular for men (52% 
less than the amount spent on those aged 75–84). In this age group stroke expenditure for 
women ($74 million) was 1.7 times as high as that for men ($44 million), reflecting the 
smaller proportion of men aged 85 and over (Figure 4.7 and Table D4). 
 
Source: Disease Expenditure Database, AIHW. 
Figure 4.7: Health-care expenditure for stroke, by age and sex, Australia, 2008–09 
 
 
 
Overall per person expenditure on stroke was $28 in 2008–09. Similar amounts were spent on 
males ($29) and females ($27). Per person expenditure remained quite low for both men and 
women until the 55–64 age group (under $50) after which became progressively greater until 
age 85 and over when expenditure per person was $367 for men and $309 for women. This 
reflects the high prevalence of stroke among the oldest age group (Figure 4.8 and Table D6). 
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Source: Disease Expenditure Database, AIHW. 
Figure 4.8: Per person health-care expenditure for stroke, by age and sex, Australia, 2008–09 
By far the greatest amount of health-care expenditure for stroke (92%) was allocated for 
hospital admitted patient services with male expenditure ($290 million) slightly higher than 
that for females ($270 million). Expenditure for out–of–hospital medical expenses and 
prescription pharmaceuticals was similar for males and females but together accounted for 
only 8% of total stroke expenditure (Figure 4.9 and Table D4). 
 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where stroke was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 4.9: Health-care expenditure for stroke, by sex and health-care sector, Australia, 2008–09 
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Other cardiovascular diseases 
In 2008–09, total allocated health-care expenditure for Other CVD—that is all cardiovascular 
diseases except CHD and stroke (see Appendix B)—was $2,581 million for males and 
$2,390 million for females. A higher proportion of health-care expenditure for Other CVD 
was spent in the 0–34 age group (5%) than for stroke (3%) or CHD (2%). This may be the 
result of the inclusion of diseases such as acute rheumatic fever and rheumatic heart disease 
which affect a proportionally higher number of younger people.  
Expenditure became progressively greater with age from age 35–44 to 75–84, for both males 
and females. It was higher for men than women between the ages 45– 84, after which 
expenditure was higher for women. The highest level of expenditure for men ($676 million) 
was reached at 65–74 and at 75–84 for women ($638 million). Expenditure was lower for 
those aged 85 and over, for males in particular (68% less) (Figure 4.10 and Table D5). 
  
Source: Disease Expenditure Database, AIHW. 
Figure 4.10: Health-care expenditure for Other cardiovascular diseases, by age and sex, Australia, 
2008–09 
Overall per person expenditure on Other CVD was $230 in 2008–09. More was spent on 
males ($240) than on females ($220). Per person expenditure for Other CVD became 
progressively higher from age 35–44 for both men and women. Expenditure per person was 
higher for men than for women from age 45–54 onwards. For both sexes the highest level of 
per person expenditure was for people aged 85 and over ($1,772 for men and $1,336 for 
women) (Figure 4.11 and Table D6). 
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Source: Disease Expenditure Database, AIHW. 
Figure 4.11: Health-care expenditure for Other cardiovascular diseases, per person, by age and sex, 
Australia, 2008–09 
Overall health-care expenditure for Other CVD was more evenly distributed across health 
sectors and by sex than it was for stroke or CHD. Hospital admitted patient services 
expenditure for males ($1,360 million) was 1.3 times as high as it was for females 
($1,023 million). In contrast, expenditure on out–of–hospital medical expenses and 
prescription pharmaceuticals was slightly higher for females than for males. (Figure 4.12 and 
Table D5). 
 
Notes:  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where Other CVD was the principal 
diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 4.12: Health-care expenditure for Other cardiovascular diseases, by area of expenditure and 
sex, Australia, 2008–09  
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5 Where does the money go? 
All cardiovascular diseases 
In 2008–09, health-care expenditure for all CVD, for people aged 34 years and below, was 
fairly similar for hospital admitted patients ($144 million) and out-of-hospital medical 
expenses ($114 million). Prescription pharmaceuticals required substantially less funding 
($28 million). This situation changed markedly after age 35 with expenditure for hospital 
admitted patients becoming progressively greater with age, until reaching $1,252 million for 
those aged 75–84. Expenditure on out-of-hospital medical expenses was greatest at age 65–74 
($377 million). Up to age group 25–34, expenditure for prescription pharmaceuticals was 
about a quarter of that for out-of-hospital medical expenses but by age 45–54 a similar 
amount was being spent on each. After age 45–54 expenditure for both was comparable in 
each age group, with the highest value being prescription pharmaceutical expenditure for 
those aged 65–74 ($453 million) (Figure 5.1 and Table D2).  
 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CVD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 5.1: Health-care expenditure for all cardiovascular diseases, by age and health-care sector, 
Australia, 2008–09 
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Coronary heart disease 
In 2008–09, CHD expenditure for hospital admitted patients, out-of-hospital medical 
expenses and prescription pharmaceuticals was relatively low until age 25–34. Thereafter 
expenditure on hospital admitted patient services was much greater than for the other two 
sectors. For those aged 35–44, hospital admitted patient expenditure was $50 million 
(compared with $3 million for out-of-hospital medical expenses and $5 million for 
prescription pharmaceuticals). The greatest level of expenditure was $438 million for the  
65–74 age group while $123 million was spent on those aged 85 or over. The highest 
expenditure for out-of-hospital medical expenses and prescription pharmaceuticals was $60 
million and $94 million for age groups 65–74 and 75–84 respectively (Figure 5.2 and Table 
D3).  
 
Notes:  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 5.2: Health-care expenditure for coronary heart disease, by age and health-care sector, 
Australia, 2008–09 
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Stroke 
Among stroke patients, overall expenditure was highest for hospital admitted patients at all 
ages, 6-fold greater at age 75–84 ($165 million) than at age 35–44 ($25 million). Expenditure 
on out-of-hospital medical expenses and prescription pharmaceuticals remained 
comparatively low for all ages, with the highest expenditure at age 75–84 ($8 million and 
$12 million, respectively) (Figure 5.3 and Table D4). 
 
Notes:  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where stroke CVD was the principal 
diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 5.3: Health-care expenditure for stroke, by age and health-care sector, Australia, 2008–09 
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Other cardiovascular diseases 
For Other CVD, estimated expenditure was similar for hospital admitted patient services and 
out-of-hospital medical expenses from ages 25 to 44. After this, hospital admitted patient 
expenditure was highest at age 75–84 ($702 million) before nearly halving to $360 million at 
age 85 or over. Up to age 35–44, prescription pharmaceuticals expenditure was about a third 
of that for the other two sectors but by 45–54 it had reached the same level of expenditure as 
out-of-hospital medical expenses. Expenditure for out-of-hospital medical expenses and 
prescription pharmaceuticals became progressively higher thereafter to maximums of 
$313 million and $362 million at age 65–74. At age 85 and over, out-of-hospital medical 
expenses was much lower at $69 million and prescription pharmaceuticals expenditure had 
fallen to $106 million (Figure 5.4 and Table D5). 
 
Notes:  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where Other CVD was the principal 
diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: Disease Expenditure Database, AIHW. 
Figure 5.4: Health-care expenditure for other cardiovascular diseases, by age and health-care sector, 
Australia, 2008–09 
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6 Expenditure per hospitalisation 
Box 6.1 Per separation expenditure estimates 
In this chapter the number of hospital separations with a principal diagnosis of CVD is used 
as the denominator to calculate ‘per separation’ costs for hospital admitted patient services 
(see ‘separation’ in glossary). Information has not been presented for out-of-hospital 
medical expenses and prescription pharmaceuticals because there is no appropriate 
administrative data source. 
All cardiovascular diseases 
For all CVD, average per separation expenditure for hospital admitted patients was $9,982 
for males and $8,634 for females. Expenditure was lower at age 25–34 compared with 0–24, 
after which it became greater with age for both sexes until age 85. Expenditure was greatest 
at age 75–84: $11,453 for males and $9,948 for females. (Figure 6.1 and Table D7). 
 
Note: Expenditure for hospital admitted patient services includes only cases where CVD was the principal diagnosis. 
Source: Disease Expenditure Database and National Hospital Morbidity Database, AIHW. 
Figure 6.1: Average expenditure per separation, hospital admitted patients, all cardiovascular 
diseases, by age and sex, Australia, 2008–09 
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Coronary heart disease 
For CHD, average per separation expenditure for hospital admitted patient services was 
$10,368 for males and $8,685 for females. Per separation expenditure was greater for females 
until age 25–34 when it was $7,814 for males and $7,940 for females. Per separation 
expenditure then became progressively smaller for women until age 45–54 ($7,281 per 
separation). For males, per separation expenditure became progressively greater with age 
until age 65-74. Expenditure was greatest for men and women at age 65–74: $9,386 for 
women and $11,137 for men. From age 75–84, per separation expenditure declined for both 
males and females (Figure 6.2 and Table D7).  
 
Note: Expenditure for hospital admitted patient services includes only cases where coronary heart disease was the principal diagnosis. 
Source: Disease Expenditure Database and National Hospital Morbidity Database, AIHW. 
Figure 6.2: Average expenditure per separation, hospital admitted patients, coronary heart disease, 
by age and sex, Australia, 2008–09  
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Stroke 
For stroke, overall per separation expenditure on hospital admitted patient services was 
similar for males ($15,669) and females ($15,815). Per separation expenditure was similar for 
both sexes at all ages except 25–34, where it was $26,439 for males and $19,629 for females. 
The highest level of expenditure was at age 25–34 for males and 0–24 for females ($25,610 per 
separation), after which expenditure became progressively smaller with age for both males 
and females. For males this continued until 75–84 ($14,434 per separation) and for females 
continued until 85 or over ($13,941 per separation) (Figure 6.3 and Table D7). 
 
Note: Expenditure for hospital admitted patient services includes only cases where stroke was the principal diagnosis. 
Source: Disease Expenditure Database and National Hospital Morbidity Database, AIHW. 
Figure 6.3: Average expenditure per separation, hospital admitted patients, stroke, by age and sex, 
Australia, 2008–09  
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Other cardiovascular diseases 
For Other CVD, the average per separation expenditure for hospital admitted patient 
services was $9,021 for males and $7,692 for females. Expenditure per separation was lower 
at age 25–34 than 0–24 for both males ($5,628 and $7,035 respectively) and females  
($4,861 and $6,760 respectively). Per separation expenditure then became progressively 
higher with age for both sexes, until age 75–84 when it was $11,376 for males and $9,479 for 
females. Expenditure at age 85 or over was lower than for the preceding age group, for males 
($10,646) and females ($9,316) (Figure 6.4 and Table D7). 
 
Note: Expenditure for hospital admitted patient services includes only cases where Other CVD was the principal diagnosis. 
Source: Disease Expenditure Database and National Hospital Morbidity Database, AIHW. 
Figure 6.4: Average expenditure per separation, hospital admitted patients, other cardiovascular 
diseases, by age and sex, Australia, 2008–09  
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7 Changes in expenditure over time 
In order to enable the comparison of health-care expenditure over time, the data presented in 
this chapter are derived using burden of disease coding for CVD instead of the ICD-10-AM 
codes used in the rest of the report (see Appendix A). As a result, totals for 2008–09 will 
differ slightly from those presented elsewhere in the report. 
Trends in overall expenditure  
Between 2000–01 and 2008–09, after adjusting for inflation within the health system, total 
expenditure for CVD increased by 48%, from $5,207 million to $7,717 million (Figure 7.1 and 
Table D9). Average annual growth in CVD expenditure of 6% per year was the same as that 
for expenditure on all diseases. Total expenditure for CVD remained at about 12% of total 
allocated expenditure for all diseases between 2000–01 and 2008–09 (Figure 7.1 and 
Table D8).  
 
Note: Expenditure figures have been adjusted to account for the effects of inflation. See ‘constant prices’ in glossary. 
Source: AIHW Disease expenditure database. 
Figure 7.1: Cardiovascular disease expenditure, constant prices, Australia, 2000–01, 2004–05, 2008–09 
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Trends in expenditure by health-care sector 
Between 2000-01 and 2008-09, the largest expenditure increase, by health-care sector, was for 
hospital admitted patient services, where CVD expenditure increased by 55%, from 
$2,907 million to $4,518 million. In 2000–01, hospital admitted patient services accounted for 
56% of CVD expenditure and by 2008–09 this had risen to 59%. CVD expenditure on  
out-of-hospital medical expenses increased 35%, from $1,125 to $1,521 and for prescription 
pharmaceuticals it increased by 43%, from $1,176 to $1,678, with most of this increase (41%) 
occurring between 2000–01 and 2004–05 (Figure 7.2 and Table D9).  
Notes  
1. Expenditure for hospital admitted patient services includes only cases where cardiovascular disease was the principal diagnosis. 
2. Expenditure figures have been adjusted to account for the effects of inflation. See ‘constant prices’ in glossary. 
Source: AIHW Disease expenditure database. 
Figure 7.2: Cardiovascular disease expenditure, by health-care sector, constant prices, Australia, 
2000–01, 2004–05, 2008–09 
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8 Discussion 
CVD has the highest health-care expenditure of any disease group in Australia and allocated 
expenditure rose 48% from 2000–01 to 2008–09, after the effects of inflation were taken into 
account. 
The greatest expenditure increase over this period was in the area of hospital admitted 
patients, where it increased 55%. By 2008–09, hospital admitted patients accounted for 59% 
of allocated CVD expenditure. Over the 2000–01 to 2008–09 period there was a parallel 
increase in the number of hospital procedures, such as coronary angiographs and 
percutaneous coronary interventions, used to diagnose and treat CVD (AIHW 2011).  
The 43% increase in expenditure on prescription pharmaceuticals used to treat CVD, 
between 2000–01 and 2008–09, in part reflects the substantial increase in the use of  
lipid-modifying medicines (statins) to control blood cholesterol, a risk factor for CVD that 
affects 1 in 3 Australians (ABS 2013a). Although, as explained in the Methods and limitations 
section, unless statins are specifically prescribed for the treatment of CVD, rather than high 
blood cholesterol, the associated expenditure will not be recorded as prescription 
pharmaceutical expenditure for CVD. In 2009, the Australian Statistics on Medicine 
publication (DoHA 2011) reported government spending of $2.3 billion on PBS/RPBS items 
for the cardiovascular system. It listed statins as two of the top three drugs by cost on the 
PBS/RPBS, amounting to almost half (approximately $1 billion) of all medications for the 
cardiovascular system.  
Stroke is an expensive disease to treat across a lifetime. After a first stroke, there is an 
increased risk of further strokes, disability and mortality (Hardie et al. 2004). A study using 
data from the North East Melbourne Stroke Incidence Study (NEMESIS) (Cadilhac et al. 
2009) estimated that for first time ischaemic and intracerebral haemorrhagic strokes that 
occurred in 2004, the total lifetime costs, in 2004 figures, unadjusted for inflation, were 
approximately $2 billion—$700 million of which related to expenditure in the first year. 
The significant amount of money spent on the prevention and treatment of CVD has resulted 
in some positive outcomes, in particular improved survival from CVD. For example, the 
number of deaths of CVD patients occurring in hospital fell 9.5% between 2000–01 and  
2011–12, from 17,601 deaths to 16,008. The proportion of CVD hospitalisations resulting in 
‘in-hospital’ deaths also fell—from 7.2% in 2000–01 to 5.3% in 2011–12—demonstrating the 
declining likelihood that someone hospitalised with CVD will die in hospital. Furthermore, 
between 2000–01 and 2011–12, the proportion of CVD deaths attributable to CHD and stroke 
combined fell from 55.6% to 50.4%.  
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Appendix A Classification of diseases  
Table A1: International classification of disease (ICD) codes for disease categories used in this 
report 
Disease group ICD–10–AM codes 
All Cardiovascular diseases I00 to I99 
Coronary heart disease I20 to I25 
Stroke I60 to I64 
Other cardiovascular diseases Balance of cardiovascular diseases 
Hypertensive diseases I10 to I15 
Other cerebrovascular diseases I65 to I69 
Peripheral vascular diseases I70 to I74 
Heart failure and cardiomyopathy I50, I42.0, I42.5–I42.9, I43 
Uncategorised cardiovascular diseases Balance of other cardiovascular diseases 
 
Table A2: Burden of disease (BoD) codes used for cardiovascular disease expenditure trends and 
expenditure comparison by disease group in this report 
Disease group ICD–10–AM codes 
All Cardiovascular diseases I00 to I99 (minus part I12, part I13, I85), G45 and G46 
Coronary heart disease I20 to I25 and part I46, I47.2, I50, I51.5–9, I70.9 
Stroke G45 and I60 to I64 
Other cardiovascular diseases Balance of cardiovascular diseases 
Source: AIHW: Begg et al. 2007. 
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Appendix B Cardiovascular diseases and 
associated risk factors 
Cardiovascular diseases (CVD) are also known as circulatory diseases, or heart, stroke and 
vascular diseases, and cover all diseases and conditions of the heart and blood vessels. There 
can be many causes of CVD.  
In Australia, the main underlying cause of CVD is atherosclerosis. This is a condition in 
which there are abnormal build-ups in the inner lining of the arteries. Made up of fat, 
cholesterol and fibre-like substances, these build-ups are known as plaque. They are most 
serious when they affect the blood supply to the heart (causing angina or heart attack) or to 
the brain (which can lead to stroke). The process leading to atherosclerosis is slow and 
complex, often starting in childhood and progressing with age.  
Coronary heart disease and stroke are the most common cardiovascular causes of death. 
Between them, they accounted for 66% of all deaths from CVD in 2011 (ABS 2013c). 
Coronary heart disease 
Coronary heart disease (CHD), also known as ischaemic heart disease, is the largest single 
cause of death for males and females in Australia, accounting for 21,513 deaths in 2011 (ABS 
2013c). In 2003, CHD was the leading cause of disease burden for males and the second 
leading cause for females (AIHW: Begg et al. 2007). There are two major clinical forms of 
CHD ― heart attack and angina.  
A heart attack occurs when a coronary plaque suddenly breaks open. This brings on a blood 
clot that completely blocks blood flow to the heart muscle. This is a life-threatening 
emergency which can cause severe chest pain, and possibly collapse and sudden death. If the 
clot is not promptly treated, some of the heart muscle will die, a condition known as acute 
myocardial infarction (AMI).  
Angina occurs when a plaque has narrowed a coronary artery to the point where the blood 
flow cannot increase to meet extra demands incurred by physical activity or strong emotion, 
resulting in temporary chest pain. Angina is generally not life-threatening, although people 
with it are more prone to sudden cardiac death or AMI than the general population.  
Stroke 
Cerebrovascular diseases were responsible for 11,251 deaths in 2011, and were the third 
leading cause of death among males and the second leading cause of death among females 
(ABS 2013c). Stroke (the main form of cerebrovascular disease) was the fifth leading specific 
cause of disease burden for males and the third leading cause for females in 2003  
(AIHW: Begg et al. 2007).  
Stroke occurs when a blood vessel carrying blood to the brain is either blocked or bleeds, 
resulting in part of the brain dying from lack of blood flow. This causes loss of function of 
the affected part of the brain, leading to death or to impairment in any or all of a range of 
functions, including movement of body parts, vision, planning, communication and 
swallowing.  
 32 Health-care expenditure on cardiovascular diseases 2008–09 
There are two main types of stroke: one is caused by blood clots, plaque or other particles 
(ischaemic strokes) and the other by bleeding (haemorrhagic strokes). Ischaemic strokes 
occur much more frequently; however, haemorrhagic strokes have a much higher fatality 
rate.  
Other cardiovascular diseases 
In this report ‘Other CVD’ covers all cardiovascular conditions except CHD and stroke. 
These conditions account for a relatively high proportion of expenditure (65% of CVD 
expenditure) but data limitations mean that they cannot be reported on individually. The 
larger components of ‘Other CVD’ expenditure include hypertension and hypertensive heart 
disease (37%), peripheral vascular disease (10%), cardiomyopathy and heart failure (9%), 
cerebrovascular diseases other than stroke (2%) and acute rheumatic fever and rheumatic 
heart disease (2%). Please see Glossary for an explanation of these conditions. Expenditure 
for the majority of ‘Other CVD’ conditions is too small to count.  
Risk factors 
A number of risk factors are known to be linked to the development of CVD. Non-
modifiable risk factors (those that cannot be changed) include age, sex, family history and 
ethnicity. Modifiable factors include tobacco smoking, high blood pressure, high blood 
cholesterol, insufficient physical activity, overweight and obesity, poor nutrition and 
diabetes. They are more common among men, Aboriginal and Torres Strait Islander people, 
and people from lower socioeconomic groups (ABS 2013b; AIHW 2008).  
Results from the 2011–12 Australian Health Survey (AHS) indicate that many Australians 
remain at an increased risk of CVD as a result of the modifiable risk factors listed above (ABS 
2013b). Almost two-thirds (62.8%) of Australian adults are overweight or obese, and this has 
increased from 56.3% in 1995. High blood cholesterol, another important risk factor for CVD, 
affects about one in three Australian adults, or 5.6 million adults. Disturbingly, of those with 
measured high cholesterol, only 1 in 10 was aware that they had the condition (ABS 2013a). 
Furthermore, 1 in 5 Australian adults (21.5%) had high blood pressure, and only 5.5% of the 
Australian population aged 18 and over had an adequate intake of fruit and vegetables, both 
factors which contribute to the overall risk of CVD (ABS 2013b). In contrast, daily smoking 
rates continue to fall among Australian adults, from 22.4% in 2001 to 16.1% in 2011–12, 
demonstrating a favourable trend in a major risk factor for CVD (ABS 2013b). 
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Appendix C Data quality statement 
Disease expenditure database 
Summary of key data quality issues 
• The Disease Expenditure Database contains estimates of expenditure by disease 
category, age group and sex for each of the following areas of expenditure: admitted 
patient hospital services, out-of-hospital medical expenses, prescription pharmaceuticals, 
optometrical and dental services, community mental health services and public health 
cancer screening.  
• Estimates are derived from combining information from the National Hospital 
Morbidity Database (NHMD), the National Public Hospitals Establishments Database 
(NPHED), the Health Expenditure Database, the National Hospital Cost Data Collection 
(NHCDC) and the Bettering the Evaluation and Care of Health (BEACH) survey.  
• The database contains a conservative estimate of total expenditure and equates to about 
70% of total recurrent health expenditure.  
Description 
The Disease Expenditure Database contains estimates of expenditure by disease category, 
age group and sex for admitted patient hospital services, out-of-hospital medical expenses, 
prescription pharmaceuticals, optometrical and dental services, community mental health 
services and public health cancer screening. Definitions for admitted patient hospital 
services, out-of-hospital medical services and prescription pharmaceuticals are as follows: 
Admitted patient hospital costs refer to the cost of services for admitted patients in both 
public and private acute hospitals and psychiatric hospitals, as well as expenditure on 
medical services provided to private admitted patients in hospitals. 
Out-of-hospital medical expenses refer to the cost for services provided by, or on behalf of, 
registered medical practitioners that are funded by the Medicare Benefits Schedule (MBS), 
Department of Veterans’ Affairs, compulsory motor vehicle third-party insurance, workers’ 
compensation insurance, private health insurance funds, Australian Government premium 
rebates allocated to medical services, MBS co-payments and other out-of-pocket payments. 
They also include non-MBS medical services, such as the provision of vaccines for overseas 
travel, as well as some expenditure by the Australian Government under funding 
arrangements that are alternatives to the fees for service. They exclude medical services 
provided to public admitted patients in public hospitals and medical services provided to 
public patients at outpatient clinics in public hospitals. Also excluded are the costs for 
medical services provided to private admitted patients in hospitals, which are counted as 
part of admitted patient costs.  
Prescription pharmaceuticals refers to the cost of pharmaceuticals that are listed in the 
schedule of the pharmaceuticals under the Pharmaceutical Benefits Scheme (PBS) and the 
Repatriation Pharmaceutical Benefits Scheme (RPBS) for which pharmaceutical benefits have 
been paid or are payable. Also included are the costs for under-copayment prescriptions and 
private prescriptions. Under-copayment prescriptions are those pharmaceuticals listed in the 
PBS or RPBS, the total costs of which are equal to or less than the statutory patient 
 34 Health-care expenditure on cardiovascular diseases 2008–09 
contribution for the class of patient concerned, while private prescriptions are those 
pharmaceuticals dispensed through private prescriptions that do not fulfil the criteria for 
payment or benefit under the PBS or RPBS. 
Estimates are derived from combining information from the NHMD, the NPHED, NHCDC 
and the Health Expenditure Database.  
Proportions derived from the Bettering the Evaluation and Care of Health (BEACH) survey 
relating to 2007 to 2009 are also used in compiling the estimates for out-of-hospital medical 
expenses and prescription pharmaceuticals. The BEACH data were collected by the Family 
Medicine Research Centre of the University of Sydney in collaboration with the Australian 
Institute of Health and Welfare.  
It is not possible to allocate all expenditure on health goods and services by disease. 
Expenditure that was not able to be allocated by disease includes: capital expenditure, 
non-admitted patient hospital services, over-the-counter drugs, other health practitioner 
services (except optometry), community health services expenditure (except community 
mental health), expenditure on public health programs (except cancer screening programs), 
health administration, health aids and appliances, and patient transport (ambulance). 
Institutional environment 
The Australian Institute of Health and Welfare (AIHW) is a major national agency set up by 
the Australian Government under the Australian Institute of Health and Welfare Act 1987 to 
provide reliable, regular and relevant information and statistics on Australia’s health and 
welfare. It is an independent statutory authority established in 1987, governed by a 
management board, and accountable to the Australian Parliament through the Health 
portfolio. 
The AIHW aims to improve the health and wellbeing of Australians through better health 
and welfare information and statistics. It collects and reports information on a wide range of 
topics and issues, from health and welfare expenditure, hospitals, disease and injury, and 
mental health, to ageing, homelessness, disability and child protection. 
The Institute also plays a role in developing and maintaining national metadata standards. 
This work contributes to improving the quality and consistency of national health and 
welfare statistics. The Institute works closely with governments and non-government 
organisations to achieve greater adherence to these standards in administrative data 
collections to promote national consistency and comparability of data and reporting. 
One of the AIHW’s main functions is to work with the states and territories to improve the 
quality of administrative data and, where possible, to compile national data sets based on 
data from each jurisdiction, to analyse these data sets and disseminate information and 
statistics. 
The Australian Institute of Health and Welfare Act 1987, in conjunction with compliance with 
the Privacy Act 1988 (Cwlth), ensures that the data collections managed by the AIHW are 
kept securely and under the strictest conditions with respect to privacy and confidentiality. 
For further information, see the AIHW website <http://www.aihw.gov.au/>. 
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The BEACH survey 
The BEACH survey data 2007–08 and 2008–09 were collected by the Family Medicine 
Research Centre of the University of Sydney in collaboration with the Australian Institute of 
Health and Welfare.  
Timeliness 
The reference period for the Disease Expenditure Database is 2008–09. The Disease 
Expenditure Database can be updated only once the NHMD, NPHED, NHCDC and Health 
Expenditure Database have all been updated for the relevant financial year, which is 
currently a minimum of 15 months after the end of the financial year. 
The AIHW first published 2008–09 data from the Disease Expenditure Database in Australia’s 
health 2012 in June 2012. 
Accessibility 
The AIHW provides a variety of products that draw upon the Disease Expenditure Database 
2008–09. Published products currently available on the AIHW website include: 
• Australia’s health 2012  
• Dementia in Australia  
• Incontinence in Australia: prevalence, experience and cost 
• Diabetes expenditure in Australia 2008-09. 
Users can request data not available online or in reports via the Expenditure and Economics 
Unit on (02) 6244 1119 or by email to <expenditure@aihw.gov.au>. Requests that take longer 
than half an hour to compile are charged for on a cost-recovery basis. 
Interpretability 
Supporting information on the quality and use of the Disease Expenditure Database is 
published in Health-care expenditure on disease and injury in Australia, 2004–05 (technical notes), 
available in hard copy or on the AIHW website.  
Most important to note is that the Disease Expenditure Database estimates: 
• are a conservative estimate based on around 70% of total recurrent health expenditure  
• are only one measure of the size of the disease burden on the community (that is, the 
‘size of the problem’)  
• are not the same as loss of health due to disease  
• should not be regarded as how much would be saved if a specific disease or all diseases 
were prevented 
• are not an estimate of the total economic impact of diseases in the Australian 
community. This is because the estimates do not include costs that are not accrued by the 
health system, such as travel costs of patients, costs associated with the social and 
economic burden on carers and family, and owing to lost quality and quantity of life. 
Relevance 
Disease expenditure estimates provide a broad picture of the use of health system resources 
classified by disease group, as well as a reference source for planners and researchers 
interested in costs and use patterns for particular disease groups.  
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The Disease Expenditure Database contains a conservative estimate based on around 70% of 
total recurrent health expenditure. 
It is not possible to allocate all expenditure on health goods and services by disease. 
Expenditure that was not able to be allocated by disease includes: capital expenditure, 
non-admitted patient hospital services, over-the-counter drugs, other health practitioner 
services (except optometry), community health services expenditure (except community 
mental health), expenditure on public health programs (except cancer screening programs), 
health administration, health aids and appliances, and patient transport (ambulance). 
Readers need to bear in mind that cost-of-illness data only provide estimates of the impact of 
a disease on health-care expenditures. The estimates of the cost of treating and/or 
preventing a disease cannot be used to indicate the loss of health due to that disease.  
Care should be taken not to interpret expenditure associated with disease treatment as 
simply an estimate of the savings that would result from prevention of disease. Conversion 
of the opportunity cost—or the benefits forgone—of resources being devoted to disease 
treatment into expenditure savings involves a number of additional considerations. See, for 
example, AIHW: Mathers & Penm 1998. 
Accuracy 
Apart from hospital admitted patient services data, the method for estimating disease 
expenditure is generally a ‘top–down’ approach where total expenditure across the health 
system is estimated and then allocated to the relevant conditions. Although this method 
yields consistency, good coverage, and totals that add up to known expenditures, it is not as 
sensitive or accurate for any specific disease as a detailed ‘bottom–up’ analysis of actual costs 
incurred by patients with that disease. In most cases, a bottom-up analysis is not possible 
due to a lack of available data. 
Both out-of-hospital medical expenses and prescription pharmaceuticals expenditure 
estimates draw upon proportions derived from BEACH surveys relating to 2007 to 2009. In 
each BEACH survey, the vocationally registered GPs and all general practice registrars who 
claimed a minimum of 375 general practice A1 Medicare items in the most recently available 
3 months make up the population from which a sample is drawn (Britt et al. 2009). GPs are 
randomly selected from this population and approached for participation in the survey. Each 
BEACH survey includes a sample of 1,000 recognised practising GPs across the country 
(about 6% of all recognised practising GPs) completing details for 100 consecutive GP 
encounters. Each BEACH survey contains details of about 100,000 encounters between GPs 
and patients (about a 0.1% sample of all general practice encounters) (Britt et al. 2009). For 
further information regarding data collection methods in BEACH surveys, refer to the 
General practice activity in Australia 2008–09 report (Britt et al. 2009). In light of these sampling 
methods used, time series comparisons of expenditure estimates for out-of-hospital medical 
expenses and prescription pharmaceuticals need to be treated with caution. Refer to the data 
quality statements for the NHMD, NPHED and the Health Expenditure Database for further 
information on the accuracy of the data within these databases. 
Coherence 
To ensure consistency between the Disease Expenditure Database and associated burden of 
disease projects, the disease groups used in the 2008–09 disease expenditure estimates were 
based on the 176 diseases that were published in the Australian burden of disease studies 
(AIHW: Mathers et al. 1999; Begg et al. 2007). Extra categories were added to provide a more 
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comprehensive list of diseases and the two categories of ‘Symptoms, signs and ill-defined 
conditions’ and ‘Other contact with health services’ were included to cover some health 
service expenditures that cannot be allocated by disease.  
The methodologies used to estimate expenditures for admitted patient hospital services have 
remained unchanged between 2004–05 and 2008–09. Hence, time series comparisons for 
admitted patient hospital services are possible.  
While the methodologies used to estimate expenditures for out-of-hospital medical expenses 
and prescription pharmaceuticals have also remained unchanged between 2004–05 and 
2008–09, the use of the BEACH survey-based data in the methodologies has meant that time 
series comparisons for these areas of expenditure should be made with caution. 
Comparisons over time for optometrical and dental services, community mental health 
services and public health cancer screening can be made with more confidence. 
Implementation date 
6 February 2012 
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Appendix D Detailed statistical tables 
Table D1: Health expenditure on cardiovascular diseases, Australia, 2008–09 ($ million) 
Disease group 
Hospital admitted 
patient services 
Out-of-hospital medical 
expenses 
Prescription 
pharmaceuticals 
Total allocated 
expenditure 
All Cardiovascular 
diseases 4,460 1,497 1,648 7,605 
Coronary heart 
disease 1,517 201 311 2,028 
Stroke 560 21 26 606 
Other cardiovascular 
diseases 2,383 1,276 1,311 4,971 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD, stroke or Other CVD was 
the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
Source: AIHW Disease Expenditure Database. 
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Table D2: Health expenditure on all cardiovascular diseases by health-care sector, age and sex, 
Australia, 2008–09 ($ million)  
Sex 
Age 
(years) 
Hospital 
admitted 
patients 
Out-of-hospital 
medical expenses 
Prescription 
pharmaceuticals 
Total allocated expenditure 
for all cardiovascular 
diseases 
Male 0–24 40 12 6 58 
 
25–34 43 18 7 67 
 
35–44 115 35 27 177 
 
45–54 285 92 106 483 
 
55–64 548 162 196 906 
 
65–74 719 208 225 1,152 
 
75–84 711 167 203 1,081 
 
85 and 
over 251 31 53 335 
 
Total 2,711 725 822 4,259 
Female 0–24 31 18 7 55 
 
25–34 30 66 8 105 
 
35–44 78 89 21 188 
 
45–54 138 81 73 292 
 
55–64 228 141 162 532 
 
65–74 360 169 228 756 
 
75–84 541 154 239 934 
 
85 and 
over 343 54 88 485 
 
Total 1,749 772 826 3,347 
Persons 0–24 71 30 13 113 
 
25–34 73 84 15 172 
 
35–44 193 124 48 365 
 
45–54 423 173 179 775 
 
55–64 777 303 358 1,438 
 
65–74 1,079 377 453 1,908 
 
75–84 1,252 322 442 2,015 
 
85 and 
over 594 85 141 820 
 Total 4,460 1,497 1,648 7,605 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CVD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
3. Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
  
 40 Health-care expenditure on cardiovascular diseases 2008–09 
Table D3: Health expenditure on coronary heart disease by health-care sector, age and sex, 
Australia, 2008–09 ($ million)  
Sex Age (years) 
Hospital 
admitted patients 
Out-of-hospital 
medical expenses 
Prescription 
pharmaceuticals 
Total allocated expenditure 
for coronary heart disease 
Male 0–24 0.4 0.1 2 2 
 
25–34 4 0.4 0.6 5 
 
35–44 39 2 5 46 
 
45–54 137 12 26 175 
 
55–64 269 23 44 336 
 
65–74 317 36 52 405 
 
75–84 238 25 55 318 
 
85 and over 56 7 14 77 
 
Total 1,061 106 198 1,365 
Female 0–24 0.2 0.1 1 2 
 
25–34 2 22 0.0 23 
 
35–44 11 0.4 0.6 12 
 
45–54 35 12 7 54 
 
55–64 73 14 15 102 
 
65–74 121 24 33 178 
 
75–84 147 17 39 203 
 
85 and over 67 5 18 90 
 
Total 456 94 113 663 
Persons 0–24 0.6 0.2 3 4 
 
25–34 6 22 0.6 28 
 
35–44 50 3 5 58 
 
45–54 172 24 32 229 
 
55–64 343 37 59 438 
 
65–74 438 60 86 583 
 
75–84 385 42 94 521 
 
85 and over 123 13 31 167 
 Total 1,517 201 311 2,028 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
3. Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
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Table D4: Health expenditure on stroke by health-care sector, age and sex, Australia, 2008–09 
($ million)  
Sex Age (years) 
Hospital 
admitted patients 
Out-of-hospital 
medical expenses 
Prescription 
pharmaceuticals 
Total allocated expenditure 
for stroke 
Male 0–24 5 0.0 0.0 5 
 
25–34 7 0.3 0.0 7 
 
35–44 12 0.6 0.1 13 
 
45–54 28 0.5 0.3 29 
 
55–64 48 2 2 52 
 
65–74 66 3 2 71 
 
75–84 82 3 6 91 
 
85 and over 42 0.7 2 44 
 
Total 290 10 13 313 
Female 0–24 4 0.0 0.6 5 
 
25–34 4 0.0 0.0 4 
 
35–44 13 0.2 0.0 13 
 
45–54 22 0.6 0.8 24 
 
55–64 30 1 0.8 32 
 
65–74 45 2 3 49 
 
75–84 83 5 5 93 
 
85 and over 70 3 2 74 
 
Total 270 11 12 293 
Persons 0–24 9 0.0 0.6 10 
 
25–34 10 0.3 0.0 11 
 
35–44 25 0.8 0.2 26 
 
45–54 51 1 1 53 
 
55–64 78 3 3 84 
 
65–74 111 4 5 120 
 
75–84 165 8 12 184 
 
85 and over 111 3 4 119 
 Total 560 21 26 606 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where stroke was the principal diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
3. Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
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Table D5: Health expenditure on Other cardiovascular diseases by health-care sector, age and sex, 
Australia, 2008–09 ($ million) 
Sex Age (years) 
Hospital 
admitted patients 
Out-of-hospital 
medical expenses 
Prescription 
pharmaceuticals 
Total allocated expenditure 
for Other cardiovascular 
diseases 
Male 0–24 34 12 4 50 
 
25–34 32 17 6 55 
 
35–44 64 32 22 118 
 
45–54 119 79 80 278 
 
55–64 231 136 150 517 
 
65–74 336 169 171 676 
 
75–84 391 140 141 672 
 
85 and over 154 23 37 214 
 
Total 1,360 609 611 2,581 
Female 0–24 27 17 5 49 
 
25–34 25 45 8 78 
 
35–44 54 88 20 162 
 
45–54 81 68 65 214 
 
55–64 126 126 146 398 
 
65–74 195 143 191 529 
 
75–84 311 132 195 638 
 
85 and over 206 46 68 321 
 
Total 1,023 667 700 2,390 
Persons 0–24 61 29 9 100 
 
25–34 57 62 14 133 
 
35–44 117 120 42 280 
 
45–54 200 148 145 493 
 
55–64 357 263 296 915 
 
65–74 530 313 362 1,205 
 
75–84 702 272 336 1,310 
 
85 and over 360 69 106 534 
 Total 2,383 1,276 1,311 4,971 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where Other CVD was the principal 
diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
3. Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
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Table D6: Health expenditure on different cardiovascular diseases per person, by age and sex, 
Australia, 2008–09 ($) 
Sex Age (years) All CVD Expenditure  CHD Expenditure  Stroke Expenditure Other CVD Expenditure 
Male 0–24 16 0.6 1 14 
 
25–34 44 3 5 36 
 
35–44 114 30 8 76 
 
45–54 327 119 20 189 
 
55–64 747 277 43 426 
 
65–74 1,549 545 96 908 
 
75–84 2,496 734 211 1,552 
 
85 and over 2,776 636 367 1,772 
 
Total 397 127 29 240 
Female 0–24 16 0.4 1 14 
 
25–34 70 15 3 52 
 
35–44 119 8 8 103 
 
45–54 194 36 16 143 
 
55–64 435 83 26 325 
 
65–74 976 229 63 683 
 
75–84 1,717 374 171 1,172 
 
85 and over 2,020 375 309 1,336 
 Total 309 61 27 220 
Persons 0–24 16 0.5 1 14 
  25–34 57 9 4 44 
  35–44 117 19 8 90 
  45–54 260 77 18 165 
  55–64 590 180 34 376 
  65–74 1,256 384 79 793 
  75–84 2,062 533 188 1,340 
  85 and over 2,273 462 329 1,482 
  Total 352 94 28 230 
Notes: 
1 Only includes expenditure for hospital admitted patients, out-of-hospital medical expenses and prescription pharmaceuticals 
2 Per person expenditure was calculated using the Australian population at 30 December 2008. 
3 Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
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Table D7: Hospital admitted patient services expenditure on different cardiovascular diseases per 
hospital separation, by age and sex, Australia, 2008–09 ($) 
Sex Age (years) All CVD Expenditure  CHD Expenditure  Stroke Expenditure Other CVD Expenditure 
Male 0–24 7,705 5,505 24,682 7,035 
  25–34 6,609 7,814 26,439 5,628 
  35–44 7,084 9,343 19,733 5,583 
  45–54 8,309 9,755 18,018 6,395 
  55–64 9,484 10,239 16,208 8,093 
  65–74 10,948 11,137 15,200 10,221 
  75–84 11,453 10,801 14,434 11,376 
  85 and over 10,480 8,364 14,567 10,646 
  Total 9,982 10,368 15,669 9,021 
Female 0–24 7,493 8,184 25,610 6,760 
  25–34 5,495 7,940 19,629 4,861 
  35–44 6,142 7,793 20,969 5,053 
  45–54 6,646 7,281 19,502 5,438 
  55–64 7,592 8,133 18,372 6,449 
  65–74 9,080 9,386 16,630 8,075 
  75–84 9,948 9,249 14,629 9,479 
  85 and over 9,686 8,101 13,941 9,316 
  Total 8,634 8,685 15,815 7,692 
Persons 0–24 7,611 6,341 25,091 6,913 
  25–34 6,097 6,399 23,431 5,347 
  35–44 6,672 7,990 20,361 5,498 
  45–54 7,681 8,464 18,645 6,246 
  55–64 8,837 8,896 16,972 7,956 
  65–74 10,245 9,217 15,746 10,445 
  75–84 10,750 7,832 14,532 12,545 
  85 and over 10,007 5,056 14,169 13,217 
  Total 9,406 8,109 15,739 9,475 
Notes 
1 Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where CHD, stroke or Other CVD was 
the principal diagnosis. 
2 Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
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Table D8: Allocated health expenditure in current and constant prices, Australia, by 
year ($ billion)  
  Total expenditure Total expenditure  Expenditure on CVD  CVD as % of total expenditure 
   (current prices) (in 2008–09 prices) (in 2008–09 prices) (in 2008–09 prices) 
2000–01 33.9 42.9 5.2 12.1 
2004–05 44.3 49.8 6.4 12.9 
2008–09 65.1 65.1 7.7 11.8 
Note: Only includes expenditure for hospital admitted patients, out-of-hospital medical expenses and prescription pharmaceuticals. 
Source: AIHW Disease Expenditure Database. 
 
Table D9: Summary of Health expenditure on cardiovascular diseases, constant prices, by CVD 
type, Australia, and year ($ million) 
Year 
Hospital admitted 
patients 
Out-of-hospital 
medical expenses 
Prescription 
pharmaceuticals 
Total expenditure allocated for 
cardiovascular diseases 
2000–01 
    All CVD 2,907 1,125 1,176 5,207 
CHD 1,286 187 174 1,647 
Stroke 430 39 25 495 
Other CVD 1,190 899 977 3,066 
2004–05     
All CVD 3,481 1,287 1,654 6,422 
CHD 1,510 194 280 1,984 
Stroke 479 48 60 587 
Other CVD 1,492 1,046 1,313 3,851 
2008–09     
All CVD 4,518 1,521 1,678 7,717 
CHD 1,869 201 311 2,381 
Stroke 631 44 57 732 
Other CVD 2,019 1,276 1,311 4,605 
Notes  
1. Expenditure for hospital admitted patient services for cardiovascular diseases includes only cases where Other CVD was the principal 
diagnosis. 
2. Out-of-hospital medical expenses and prescription pharmaceuticals are reliant on sample survey data that can vary from year to year. 
3. Row and column totals may not add up exactly due to rounding. 
Source: AIHW Disease Expenditure Database. 
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Glossary 
acute rheumatic fever: A delayed complication of an untreated throat infection from 
Group A Streptococcus bacteria. It can involve the heart valves, and the heart muscle and its 
lining. The long-term damage to the heart that results from acute rheumatic fever is referred 
to as rheumatic heart disease.  
allocated health-care expenditure: The spending on health goods and services which can be 
allocated by a specific disease type. Unless otherwise specified, ‘expenditure’ in this report 
refers to allocated health-care expenditure. 
Atherosclerosis: A process in which fatty and fibre-like deposits build up on the inner walls 
of arteries, often forming plaques that can then cause blockages. It is the main underlying 
condition in heart attack, angina, stroke and peripheral vascular disease.  
blood cholesterol: Fatty substance produced by the liver and carried by the blood to supply 
the rest of the body. Its natural function is to supply material for cell walls and for steroid 
hormones, but if levels in the blood become too high this can lead to atherosclerosis and 
heart disease. 
capital expenditure: Spending (expenditure) on large-scale fixed assets (for example, new 
buildings and equipment with a useful life extending over a number of years). 
cardiomyopathy and heart failure: Occur when the heart is damaged or overloaded and 
becomes less effective in pumping blood around the body. Cardiomyopathy is a disease 
where the heart muscle becomes enlarged, thickened or stiff. As this can reduce the 
effectiveness of the heart, cardiomyopathy and heart failure commonly occur together.  
cardiovascular disease: Any disease of the circulatory system, namely the heart (cardio) or 
blood vessels (vascular). It includes heart attack, angina, stroke, heart failure and peripheral 
vascular disease. Also known as circulatory disease. 
cerebrovascular disease: Any disorder of the blood vessels supplying the brain or its 
covering membranes. A notable and major form of cerebrovascular disease is stroke. 
constant prices: Dollar amounts for different years that are adjusted to reflect the prices in a 
chosen reference year. This provides a way of comparing spending over time on an equal 
value-for-value basis without the distorting effects of inflation. The comparison will reflect 
only the changes in the amount of goods and services purchased—changes in the ‘buying 
power’—not the changes in prices of these goods and services caused by inflation. Compare 
with current prices. 
coronary heart disease: Disease due to blockages in the heart’s own (coronary) arteries, 
expressed as angina or a heart attack. Also known as ischaemic heart disease. 
current prices: Dollar amounts reported for a particular year, unadjusted for inflation. 
Changes in current price expenditures reflect changes in both price and volume. Compare 
with constant prices. 
hospital admitted patient: A patient who undergoes a hospital’s formal admission process 
to receive treatment and/or care. This treatment and/or care are provided over a period of 
time and can occur in hospital and/or in the person’s home (for hospital-in-the-home 
patients).  
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Hospitalisation: Synonymous with admission and separation, that is, an episode of hospital 
care that starts with the formal admission process and ends with the formal separation 
process. 
Hypertension: (also known as high blood pressure) is a condition where the forces exerted 
by blood on the walls of arteries are higher than normal. Hypertension is a major risk factor 
for coronary heart disease, stroke, peripheral vascular disease, heart failure and kidney 
failure. A complication of hypertension is hypertensive heart disease, where high blood 
pressure is prolonged or severe enough to cause damage to the heart.  
International Classification of Diseases: The World Health Organization’s internationally 
accepted classification of death and disease. The 10th revision (ICD-10) is currently in use. 
ICD-10-AM is the Australian modification of ICD-10, used for diagnoses and procedures 
recorded for patients admitted to hospitals. 
non-admitted patient: A patient who receives care from a recognised non-admitted patient 
service/clinic of a hospital, including emergency departments and outpatient clinics. 
other cerebrovascular diseases: Encompasses all other disorders of the blood vessels 
supplying the brain or its covering membranes, with the exception of stroke, which is treated 
separately in this report. 
out-of-hospital medical expenses: The cost for services provided by, or on behalf of, 
registered medical practitioners to non-admitted patients. Includes the cost of consultations 
and services such as imaging, pathology and diagnostic services.  
out-of-pocket costs: The total costs incurred by individuals for health-care services over and 
above any refunds from Medicare and private health insurance funds. 
peripheral vascular disease: Affects the arteries outside the heart, especially those supplying 
the legs. It occurs when fatty deposits build up on the inner walls of arteries, reducing blood 
circulation. In severe cases, a limb-threatening reduction of blood circulation can lead to 
amputation. 
Pharmaceutical Benefits Scheme (PBS): A national, government-funded scheme that 
subsidises the cost of a wide range of pharmaceutical drugs for all Australians to help them 
afford standard medications. 
Prevalence: The number or proportion (of cases, instances, and so forth) in a population at a 
given time. 
principal diagnosis: The diagnosis listed in hospital records to describe the problem that 
was chiefly responsible for hospitalisation. 
recurrent spending: Spending (expenditure) on goods and services that are used during the 
year, for example, salaries. It may be contrasted with capital spending. 
Repatriation Pharmaceutical Benefits Scheme (RPBS): This scheme provides assistance to 
eligible veterans (with recognised war or service-related disabilities) and their dependents 
for both pharmaceuticals listed on the PBS and a supplementary repatriation list, at the same 
cost as patients entitled to the concessional payment under the PBS. 
risk factor: Any factor which represents a greater risk of a health disorder or other unwanted 
condition or event. Some risk factors are regarded as causes of disease, others are not 
necessarily so. Along with their opposites, protective factors, risk factors are known as 
determinants. 
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separation The formal process where a hospital records the completion of an episode of 
treatment and/or care for an admitted patient. In this report, described by the term 
hospitalisation. 
stroke When an artery supplying blood to the brain suddenly becomes blocked or bleeds. 
Often causes paralysis of parts of the body normally controlled by that area of the brain, or 
speech problems and other symptoms. 
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Health-care expenditure on 
cardiovascular diseases 
2008–09 
Cardiovascular disease (CVD) makes a considerable 
impact on the health of Australians and has the highest 
level of health-care expenditure of any disease group.
Between 2000–01 and 2008–09, health-care expenditure 
allocated to CVD increased by 48% from $5,207 million 
to $7,717 million.
The health-care sector with the largest increase (55%) 
was hospital admitted patients.
